emicizumab

Italy

Drugs containing this active substance

  • HEMLIBRA

    Hemlibra is used for the treatment of patients of all ages with hemophilia A (congenital factor VIII deficiency), both in those who have developed factor VIII inhibitors and in those who have not (in cases of severe or moderate disease with a severe bleeding phenotype). The medicine is used to prevent or reduce the number of bleeds.

    Form: solution for injection

    Active substance Dosage
    emicizumab -

    ATC: B02BX06

    Manufacturer: ROCHE REGISTRATION GMBH